...
首页> 外文期刊>Transplantation Proceedings >Renal pathology and clinical presentations of polyomavirus nephropathy in simultaneous kidney pancreas transplant recipients compared with kidney transplant recipients.
【24h】

Renal pathology and clinical presentations of polyomavirus nephropathy in simultaneous kidney pancreas transplant recipients compared with kidney transplant recipients.

机译:与肾脏移植受者相比,同时肾胰腺移植受者中多瘤病毒肾病的肾脏病理和临床表现。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION: The purpose of this study was to describe and compare the renal histopathology and clinical course of simultaneous kidney-pancreas transplant (SKP) recipients with kidney transplant (KT) recipients with polyomavirus nephropathy (PVN). METHODS: Between 1997 and 2002, 20 patients (7 SKP, 13 KT) were diagnosed with PVN. Clinical characteristics and outcomes of PV-N were correlated with histopathologic examinations of renal allograft biopsy and compared between SKP and KT recipients. RESULTS: There were no differences in demographics between SKP and KT recipients with PV-N. The mean time to PVN was 611 (172 to 1174) days posttransplant in SKP and 343 (83 to 720) days posttransplant in KT (P =.05). The serum creatinine at the time of diagnosis was similar between SKP and KT recipients. All patients were treated with reduction in immunosuppression. After a median follow-up of 2 years, the patient survival was 71% in SKP and 100% in KT. Four grafts (57%) were lost owing to PVN in SKP group and three grafts (23%) were lost owing to PVN in the KT group. More patients (43%) in SKP had a history of acute rejection prior to diagnosis of PVN compared to KT (8%) and biopsy-proven tacrolimus nephrotoxicity prior to PVN was more common in SKPT (86%) than in KT (8%) patients (P <.05). SKP patients with evidence of diffuse fibrosis and high total sum scores at time of presentation all subsequently lost their grafts. CONCLUSIONS: SKP recipients with PVN had a worse clinical course than KT recipients.
机译:引言:本研究的目的是描述和比较同时患有肾胰腺移植(SKP)受体和患有多瘤病毒性肾病(PVN)的肾脏移植(KT)受体的肾脏组织病理学和临床病程。方法:1997年至2002年,诊断为PVN的患者20例(7例SKP,13例KT)。 PV-N的临床特征和结局与同种异体肾活检组织病理学检查相关,并与SKP和KT接受者进行了比较。结果:PV-N的SKP和KT接受者之间的人口统计学无差异。在SKP中,到达PVN的平均时间为611(172至1174)天,而在KT中,平均时间为343(83至720)天(P = .05)。诊断时的血清肌酐在SKP和KT接受者之间相似。所有患者的免疫抑制均降低。中位随访2年后,SKP患者生存率为71%,KT患者生存率为100%。在SKP组中,由于PVN损失了4个移植物(57%),在KT组中,由于PVN损失了3个移植物(23%)。与KT(8%)相比,有更多SKP患者(43%)在诊断为PVN之前有急性排斥反应史,并且活检证实的他克莫司肾毒性在SKPT中比SKT(86%)更为常见(8%)。 )患者(P <.05)。在出现时有弥漫性纤维化迹象且总评分较高的SKP患者随后全部失去了移植物。结论:PVN的SKP接受者的临床病程比KT接受者差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号